Premium
ABCA3 mutations led to pulmonary fibrosis and emphysema with pulmonary hypertension in an 8‐year‐old girl
Author(s) -
Ota Chiharu,
Kimura Masato,
Kure Shigeo
Publication year - 2016
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.23379
Subject(s) - medicine , pulmonary fibrosis , pulmonary hypertension , interstitial lung disease , lung , respiratory distress , respiratory disease , pathology , surgery
Summary ABCA3 is highly expressed in alveolar epithelial type 2 cells and is associated with surfactant homeostasis. Patients with ABCA3 mutations develop various respiratory complications, such as fatal respiratory distress syndrome or interstitial lung disease. We describe a patient with pulmonary fibrosis and emphysema with pulmonary hypertension, associated with compound heterozygous mutations of the ABCA3 gene. This is the first report showing that mutations in the ABCA3 gene lead to pulmonary fibrosis and emphysema, including combined pulmonary fibrosis and emphysema, in childhood. Treatment with prostacyclin analogue, warfarin, and inhaled oxygen was effective to improve patient's hemodynamic condition as well as pulmonary fibrosis and emphysema. Pediatr Pulmonol. 2016;51:E21–E23 . © 2016 Wiley Periodicals, Inc.